CA2147260C — Dry powder inhaler
Assigned to Dura Pharmaceuticals Inc · Expires 1999-04-13 · 27y expired
What this patent protects
A dry powder medecine inhaler has an impeller (31) non-concentrically disposed in a mixing chamber (25). A motor spins the impeller at high speed. A plunger (106) introduces a dose of powdered medecine into the chamber so that all powder particles are available for intermixing di…
USPTO Abstract
A dry powder medecine inhaler has an impeller (31) non-concentrically disposed in a mixing chamber (25). A motor spins the impeller at high speed. A plunger (106) introduces a dose of powdered medecine into the chamber so that all powder particles are available for intermixing disaggregation and comminution. An aperture (51) receives a first stream of air and passes it towards the mouthpiece for inhalation by the user. A wall (11) has at least one aperture (59) for diverting a portion of a main air stream into the aerosolizing chamber to mix with the particles to form a fine, low density, low velocity, dry mist of powdered medecine for inhalation by the user.
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.